Find Federal Grants
Walla Walla District · W912EF-23-2-RFP-0001
Bureau of Democracy Human Rights and Labor · SFOP0009597
Bureau of Democracy Human Rights and Labor · SFOP0009598
DRL Fostering Resilience and Strategic Advocacy in Burma’s Pro-Democracy Movement
Bureau of Democracy Human Rights and Labor · SFOP0009599
FY23 Law Enforcement Agency De-Escalation Grants -Community Policing Development Solicitation
Community Oriented Policing Services · O-COPS-2023-171550
Bureau of Population Refugees and Migration · SFOP0009616
Community Oriented Policing Services · O-COPS-2023-171549
FY23 Continuation and Expansion of Regional De-Escalation Training Centers - Community Policing Development Solicitation
Community Oriented Policing Services · O-COPS-2023-171551
Community Oriented Policing Services · O-COPS-2023-171556
Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-23-023
Defense Health Agency Contracting Activity - DHACA · HT9425-23-SCIRP-CTA
Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional)
National Institutes of Health · RFA-OD-23-015
Bureau of Counterterrorism · SFOP0009615
Defense Health Agency Contracting Activity - DHACA · HT9425-23-SCIRP-CTRA
Defense Health Agency Contracting Activity - DHACA · HT9425-23-SCIRP-IIRA
Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)
National Institutes of Health · PAR-23-153
Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)
National Institutes of Health · PAR-23-152
Defense Health Agency Contracting Activity - DHACA · HT9425-23-SCIRP-TRA
ROSES 2023: A.59 Technology Development for Support of Wildland Fire Science, Management, and Disaster Mitigation
NASA Headquarters · NNH23ZDA001N-FIRET
Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)
National Institutes of Health · PAR-23-148